SANA Kliniken Oberfranken Coburg GmbH — Clinical Trial Site

16 Registered trials

8 Currently recruiting

Organisation

SANA Kliniken Oberfranken Coburg GmbH

Location

Coburg, Germany

Identifier

ORG-100049599

Address

Ketschendorfer Strasse 33, 96450, Germany

Departments

#3215:Innere Medizin und Kardiologie
2358:Innere Medizin und Kardiologie
Cardiology and Angiology
Department of Cardiology
Hospital
II Medical Clinic - Clinic for cardiology and angiology
II. Medizinische Klinik
Internal Medicine and Cardiology#2101
Kardiologie
Klinik für Gefäßmedizin
Klinik für Kardiologie und Angiologie
N/A
Onkologisches Zentrum
Sana Kliniken Oberfranken Coburg GmbH - II. Med. Klinik, Kardiologie

Clinical trials at this site (16)

Search interface

OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
SGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION Recruiting

2025-520794-39-00 Arterial Hypertension 5 2025-12-10
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
Evaluation of efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes Recruiting

2025-521670-34-00 Acute coronary syndrome (ST-elevation myocardial infarc 5 2026-03-04
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation. Recruiting

2025-521377-14-00 Atrial fibrillation 4 2025-10-06
A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig… Recruiting

2025-520519-14-00 Atherosclerotic Cardiovascular Disease 5 2025-09-03
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping functio… Recruiting

2024-519525-38-00 Heart failure 5 2025-08-22
A contrast medium sparing strategy using automated Carbon Dioxide Injection during PERIpheral vascular interventions for PREVENTion of Major… Recruiting

2024-512876-37-00 Peripheral Arterial Disease (PAD) 5 2025-04-11
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24
The TARGET BP I Ended

2024-512525-83-00 Hypertension 5 2020-01-07
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Heart Failure 4 2024-03-13
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial Ended

2024-518736-37-00 Risk of stroke by Atrial Fibrillation 6 2018-01-12